 | Up a level |
Garcia-Manero, Guillermo, Fenaux, Pierre, Al-Kali, Aref, Baer, Maria R., Sekeres, Mikkael A., Roboz, Gail J., Gaidano, Gianluca, Scott, Bart L., Greenberg, Peter, Platzbecker, Uwe, Steensma, David P., Kambhampati, Suman, Kreuzer, Karl-Anton, Godley, Lucy A., Atallah, Ehab, Collins, Robert, Jr., Kantarjian, Hagop, Jabbour, Elias, Wilhelm, Francois E., Azarnia, Nozar and Silverman, Lewis R. (2016). Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. Lancet Oncol., 17 (4). S. 496 - 509. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Kvasnicka, Hans Michael 
ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos, Kamalanabhaiah, Shilpa, Kantarjian, Hagop and Verstovsek, Srdan
(2015).
CD34+Hematopoietic Progenitors and Bone Marrow Angiogenesis in Patients With Myelofibrosis Following Therapy.
Mod. Pathol., 28.
S. 357A - 358.
NEW YORK:
NATURE PUBLISHING GROUP.
ISSN 1530-0285
Kvasnicka, Hans Michael, Thiele, Juergen, Bueso-Ramos, Carlos, Kamalanabhaiah, Shilpa, Kantarjian, Hagop and Verstovsek, Srdan (2015). CD34+Hematopoietic Progenitors and Bone Marrow Angiogenesis in Patients With Myelofibrosis Following Therapy. Lab. Invest., 95. S. 357A - 358. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0307
Kvasnicka, Hans Michael ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Kamalanabhaiah, Shilpa, Cortes, Jorge E., Kantarjian, Hagop and Verstovsek, Srdan
(2014).
Changes in Activated Bone Marrow Macrophages and Mast Cells in Patients with Myelofibrosis Following Ruxolitinib Therapy.
Blood, 124 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020